Abstract
Familial papillary thyroid carcinoma (PTC) is a well recognized disease. However, genetic predisposition to familial PTC is rare and the molecular alterations at the origin of the pathology are unknown. The association between PTC and lymphocytic thyroiditis (LT) has been reported recently. We communicate here 6 cases of PTC associated with LT in 2 unrelated families. PTC was diagnosed on classical nuclear and architectural criteria. It was bilateral in 5 cases. Architecture was equally distributed between typical PTC and its follicular variant. LT was present in variable degrees, including in 4 cases, oncocytic metaplasia. Using the RT-PCR technique, we observed a RET/PTC rearrangement in the carcinomatous areas of patients of both families: PTC1 in family 1 and PTC3 in family 2 and a RET/PTC rearrangement in non-malignant thyroid tissue with LT in family 2. The RET/PTC band was weaker or absent in pure LT areas. Furthermore, using a polyclonal ret antibody, an apical or a diffuse cytoplasmic ret onc protein immunolabelling was observed in the three patients with RET/PTC1 rearrangement and in the three patients with RET/PTC3 rearrangement. In conclusion our data: (1) show the presence of a RET/PTC 1 or 3 rearrangement (depending on the family) together with a variable expression of ret protein in all the PTCs; (2) suggest that the molecular event at the origin of the PTCs seems to be particular to each one of the studied families; and (3) confirm that the ret proto-oncogene activating rearrangement(s) is an early event in the thyroid tumorigenic process and that it can be observed in association with LT. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bongarzone I, Pierotti M, Monzini N, Mondellini P, Manenti G, DonghiS R, Pilotti S, Grieco M, Santoro M, Fusco A, Vecchio G and Della-Porta G (1989) High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 4: 1457–1462
Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della-Porta G and Pierotti MA (1993) Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol Cell Biol 13: 358–366
Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M and Suárez HG (1997) High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received. Oncogene 15: 1263–1273
Bunone G, Uggeri M, Mondellini P, Pierroti MA and Bongarzone I (2000) RET receptor expression in thyroid follicular epithelial cell-derived tumors. Cancer Res 60: 2845–2849
Cetta F, Chiapetta G, Mellilo RM, Petracci M, Montalto G, Santoro M and Fusco A (1998) The RET/PTC1 oncogene is activated in familial adenomatous polyposis associated thyroid papillary carcinomas. J Clin Edocrinol Metab 83: 1003–1006
Chappuis S, Geneste O, Pasini P, Lenoir G and Billaud B (1996) RET et GDNF: un récepteur orphelin trouve une famille nourricière. Médecine/Sciences 12: 1408–1413
Cho JY, Sagartz JE, Capen CC, Mazzaferri EL and Jhiang SM (1999) Early cellular abnormalities induced by RET/PTC 1 oncogene in thyroid-targeted transgenic mice. Oncogene 18: 3659–3665
Delvincourt C, Patey M, Flament JB, Suárez HG, Larbre H, Jardillier JC and Delisle MJ (1996) Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region. Clinical Biochemistry 29: 267–271
Fisher DK, Groves MD, Thomas SJ and Johnson PC (1989) Papillary carcinoma of the thyroid: additional evidence in support of a familial component. Cancer Invest 7: 323–325
Fugazzola L, Pierotti MA, Vigano E, Pacini F, Vorontsova TV and Bongarzone I (1996) Molecular and biochemical analysis of RET/PTC4 a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Oncogene 13: 1093
Gaulier A, Fourcade C, Szekeres G and Pulik M (1994) Bone marrow one step fixation-decalcification in lowy FMA solution: an immunohistological and in situ hybridization study. Pathol Res Pract 190: 1149–1161
Gorson D (1992) Familial papillary carcinoma of the thyroid. Thyroid 2: 131–132
Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della-Porta G, Fusco A and Vecchio G (1990) PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60: 557–563
Ishizaka Y, Kobayashi S, Ushijima T, Hirohashi S, Sugimura T and Nagao M (1991) Detection of ret TPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene 6: 1667–1672
Ishizaka Y, Shima H, Sugimara T and Nagao M (1992) Detection of phosphorylated RET/PTC oncogene product in cytoplasm. Oncogene 7: 1441–1444
Jhiang SM (2000) The ret proto-oncogene in human cancers. Oncogene 19: 5590–5597
Jhiang SM, Sagartz JE, Tong Q, Parker-thouburg J, Capen CC, Cho JY, Xing S and Ledend C (1996) Targeted expression of the ret/PTC 1 oncogene induces papillary thyroid carcinomas. Endocrinology 137: 375–378
Klugbauer S and Rabes HM (1999) The transcription coactivator HTIF1 and a related protein are fused to the RET receptor Tyrosine Kinase in childhood papillary thyroid carcinomas. Oncogene 18: 4388–4393
Klugbauer S, Jauch A, Lengfelder E, Demidchik E and Rabes HM (2000) A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8). Cancer Res 60: 7028–7032
Lote K, Andersen K, Nordal E and Brennhood IO (1980) Familial occurrence of papillary thyroid carcinoma. Cancer 46: 1291–1297
Mayr B, Potter E, Goretzki P, Rüschoff J, Ditmaier W, Hoang-Vu C, Dralle H and Brabant G (1999) Expression of wild type ret, RET/PTC and RET/PTC variants in papillary thyroid carcinoma in Germany. Langenbeck’s Arch Surg 384: 54–59
McKee RF, Krukowski ZH and Matheson NA (1993) Thyroid neoplasia coexistent with chronic lymphocytic thyroiditis. Brit J Surg 80: 1303–1304
Michelin S, Daya-Grosjean L, Sureau F, Saïd S, Sarasin A and Suárez HG (1993) Characterization of a c-met proto-oncogene actived in human Xeroderma pigmentosum cells after treatment with N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). Oncogene 8: 1983–1991
Nakayama S, Iida K, Tsuzuki T, Iwashita T, Murakami H, Asai N, Iwata Y, Ichihara M, Ito S, Kawai K, Asai M, Kurokawa K and Takahashi M (1999) Implication of expression of GDNF/Ret signalling componentsin differentiation of bone marrow haemopoietic cells. Br J Haematol 105: 50–57
Okayasu I, Fujiwara M, Hara Y, Tanaka Y and Rose NR (1995) Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. Cancer 76: 2312–2318
Reda G, Cesareo R, Lolli E and Gargiulo A (1997) Thyroid cancer and Hashimoto’s thyroiditis. Minerva Chir 52: 139–141
Ron E, Kleinerman RA, Livolsi VA and Fraumeni JF (1991) Familial nonmedullary thyroid cancer. Oncology 48: 309–311
Santoro M, Dathan N, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G and Fusco A (1994) Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in human thyroid papillary carcinoma. Oncogene 9: 509–516
Santoro M, Chiapetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G and Fusco A (1996) Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 12: 1821–1826
Sarasin A, Bounacer A, Lepage F, Schlumberger M and Suárez HG (1999) Mechanisms of mutagenesis in mammalian cells: application to human thyroid tumors. C. R. de l’Acad des Sciences 322: 143–149
Sclafani AP, Valdes M and Cho H (1993) Hashimoto’s thyroiditis and carcinoma of the thyroid: optimal management. Laryngoscope 130: 845–849
Soh EY and Parc S (1993) Diagnostic approach to thyroid carcinoma in Graves’ disease. Yousei Med J 34: 191–194
Soravia C, Sugg SL, Berk T, Mitri A, Cheng H, Gallinger S, Cohen Z, Asa SL and Bapat BV (1999) Familial adenomatous polyposis-associated thyroid cancer. Am J Pathol 154: 127–135
Suárez HG (1998 a) La tumorigenèse épithéliale thyroïdienne associée aux radiations. Médecine/Sciences 14: 1356–1365
Suárez HG (1998 b) Genetic alterations in epithelial human thyroid tumours. Clinical Endocrinology 48: 531–546
Sugg S, Ezzat S, Rosen IB, Freeman JL and Asa SL (1998) Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 83: 4116–4122
Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H and Hiai H (1988) Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3: 571–578
Viglietto G, Chiappetta G, Martinez-Tello FJ, Fukunaga FH, Tallini G, Rigopoulou D, Visconti R, Mastro A, Santoro M and Fusco A (1995) RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 11: 1207–1210
Walker RP and Paloyan E (1990) The relationship between Hashimoto’s thyroiditis, thyroid neoplasia and primary hyperparathyroidism. Otolaryngol Clin North Am 23: 291–302
Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M and Fusco A (1997) Expression of RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis. Laryngoscope 107: 95–100
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Mechler, C., Bounacer, A., Suarez, H. et al. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements. Br J Cancer 85, 1831–1837 (2001). https://doi.org/10.1054/bjoc.2001.2187
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2187